WHO ICTRP trial
A multicenter, randomized, double-blind, controlled clinical study of esketamine…
ChiCTR2400085495 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400085495 |
|---|---|
| Public title | A multicenter, randomized, double-blind, controlled clinical study of esketamine in the prevention of postpartum depression in women undergoing cesarean section |
| Scientific title | A multicenter, randomized, double-blind, controlled clinical study of esketamine in the prevention of postpartum depression in women undergoing cesarean section |
| Primary sponsor | The First Affiliated Hospital of Chongqing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | postpartum depression |
| Interventions | Study group:Injection of esketamine 0.25mg/kg(20ml);Control group:Injection of normal saline 20ml |
| Registration date | Jun 10, 2024 |
| Target size | Study group:733;Control group:733 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: